BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

4th Annual Asia Pacific BioScience Forum, London, 11 October 2007

Melbourne, Australia and London, United Kingdom, 31 August 2007:  Following three consecutive years of success, the 4th Annual Asia Pacific BioScience Forum will showcase a select group of Asia Pacific biotechnology companies to UK & EU investor and partnering audiences interested in the Asia Pacific region.  

Attendance is free for media, qualifying analysts, fund managers, investors, venture capitalists, biotech and pharma executives.

The day is open for all delegates to attend and hear the Company presentations. Formal and informal networking functions will be taking place throughout the day.

Organising sponsors include Intersuisse, BioScience Managers, Elixir Securities, Grant Thornton and Northbank Communications.

For more information, please visit www.aplsf.com

Or contact Annette Nason-Waters at BioScience Managers on +44 207 225 4403 or anw@biosciencemanagers.com

Interesting facts about the Australian biotechnology industry:

  • The number of core biotechnology companies in Australia has more than doubled over a period of five years to 427 in 2006.
  • As at December 2006, the market capitalisation for biotechnology and medical devices companies listed on the Australia Stock Exchange (ASX) was A$26.5 billion.
  • Approximately 50 per cent of the biotechnology companies listed on the Australia Securities Exchange (ASX) have emerged from publicly funded research agencies.
  • In 2006, Australian biotechnology companies and research organisations announced 380 partnerships, 67 per cent with overseas companies or agencies.
  • The Australian biotechnology industry has 474 therapeutic products in development.
  • With only 0.3 per cent of the world’s population, Australia contributes 2.5 per cent of the world’s media research and 2.9 per cent of global scientific publications.
  • Australia is the home of ground breaking Nobel Laureates - William Bragg (X-Ray Crystallography), John Cornforth (Enzyme Chemistry), Peter Doherty (Immunology), John Eccles (Neurophysiology), Howard Florey (Penicillin), Frank Macfarlane Burnet (Immunology), and Barry J. Marshall & J. Robin Warren (Peptic Ulcer Disease).

 Source: Australian Government Invest Australia Biotechnology Industry Report, 2007

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.